<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03726918</url>
  </required_header>
  <id_info>
    <org_study_id>BioPreIOA</org_study_id>
    <nct_id>NCT03726918</nct_id>
  </id_info>
  <brief_title>Identification of New Predictive Osseointegration Bio-Markers of the Prosthetic Implant in Patients With OsteoArthritis</brief_title>
  <acronym>BioPreIOA</acronym>
  <official_title>Identification of New Predictive Osseointegration Bio-Markers of the Prosthetic Implant in Patients With OsteoArthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istituto Ortopedico Rizzoli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istituto Ortopedico Rizzoli</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study involves the isolation and cellular, molecular and proteomic characterization of
      synoviocytes, osteoblasts and chondrocytes from tissue samples obtained from patients
      undergoing surgery of endo or arthroplasty for osteoarthritis (Experimental Group) or
      interventions for other causes such as for example periarticular fracture requiring the
      implantation of a prosthesis (Control Group)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study involves the isolation and cellular, molecular and proteomic characterization of
      synoviocytes, osteoblasts and chondrocytes from tissue samples obtained from patients
      undergoing surgery of endo or arthroplasty for osteoarthritis (Experimental Group) or
      interventions for other causes such as for example periarticular fracture requiring the
      implantation of a prosthesis (Control Group) Deeper analysis of micro Ribo Nucleic Acid (RNA)
      and Non Coding RNA expressed by the synoviocytes, osteoblasts and chondrocytes will be
      performed in order to understand their possible involvement in pathways of osteogenic
      differentiation, through suitable experimental in vitro models of co-cultures. In particular,
      investigators will focus on the cross-talk between synoviocytes and osteoblasts, cell
      populations involved in the post-surgical articular microenvironment and on which the
      osteointegration process of the joint prosthesis depends.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2018</start_date>
  <completion_date type="Anticipated">September 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>miRNAs and LncRNA</measure>
    <time_frame>at the time of surgery (Day0)</time_frame>
    <description>expression of miRNAs and LncRNA, from synoviocytes, osteoblasts and chondrocytes detected at the time of surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Biomarkers useful for predicting the efficiency of osseointegration of the implant</measure>
    <time_frame>at the time of surgery (Day0)</time_frame>
    <description>the mRNAs and the identified proteins will be analyzed through the use of specific software, such as TargetScanPrediction.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Validation of data obtained on miRNAs and lncRNAs</measure>
    <time_frame>at the time of surgery (Day0)</time_frame>
    <description>Through in vitro co-culture systems, investigators will evaluate the role of previously identified miRNAs and lncRNAs in cross-talk between osteoblasts and synoviocytes isolated from patients with osteoarthritis.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Osteoarthritis</arm_group_label>
    <description>Surgery for implantation of a prosthesis in case of Osteoarthritis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non Osteoarthritis</arm_group_label>
    <description>Surgery for implantation of a prosthesis fon non Osteoarthritis cases</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgery for implantation of a prosthesis</intervention_name>
    <description>Analysis of micro Ribo Nucleic Acid (RNA) expressed by the synoviocytes, osteoblasts and chondrocytes</description>
    <arm_group_label>Non Osteoarthritis</arm_group_label>
    <arm_group_label>Osteoarthritis</arm_group_label>
    <other_name>non-osteoarthritis arm</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      The isolated cells of synoviocytes, osteoblasts and chondrocytes from tissue samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Male and female patients of age &gt;40 years undergoing surgery of endo or arthroplasty for
        osteoarthritis or ifor other causes requiring the implantation of a prosthesis
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male and Female patients &gt; 40 years old hospitalized for surgery of endo- or
             arthroplasty for Osteoarthritis or for surgery for joint traumatic diseases (eg
             femoral neck fractures) requiring the implantation of a prosthesis

          2. Interval of at least three months from any previous infiltrative treatment of any
             kind;

          3. Patients able to provide written informed consent to the study.

        Exclusion Criteria:

          1. Severe cognitive defects or psychiatric disorders;

          2. Tumor pathologies or concurrent antineoplastic therapies;

          3. Autoimmune diseases (rheumatoid arthritis);

          4. Surgery that involves the joint
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Gianluca Giavaresi, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Isituto Ortopedico Rizzoli</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Viviana Costa, PhD</last_name>
    <phone>00390916554</phone>
    <phone_ext>630</phone_ext>
    <email>viviana.costa@ior.it</email>
  </overall_contact>
  <reference>
    <citation>Costa V, Raimondi L, Conigliaro A, Salamanna F, Carina V, De Luca A, Bellavia D, Alessandro R, Fini M, Giavaresi G. Hypoxia-inducible factor 1Î‘ may regulate the commitment of mesenchymal stromal cells toward angio-osteogenesis by mirna-675-5P. Cytotherapy. 2017 Dec;19(12):1412-1425. doi: 10.1016/j.jcyt.2017.09.007. Epub 2017 Oct 27.</citation>
    <PMID>29111380</PMID>
  </reference>
  <reference>
    <citation>Pelletier JP, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum. 2001 Jun;44(6):1237-47. Review.</citation>
    <PMID>11407681</PMID>
  </reference>
  <reference>
    <citation>Marijnissen AC, Lafeber FP. Re: E. B. Hunziker. Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. Osteoarthritis and Cartilage 2002; 10:432-63. Osteoarthritis Cartilage. 2003 Apr;11(4):300-1; author reply 302-4.</citation>
    <PMID>12681957</PMID>
  </reference>
  <reference>
    <citation>Zhang M, Lygrisse K, Wang J. Role of MicroRNA in Osteoarthritis. J Arthritis. 2017 Apr;6(2). pii: 239. doi: 10.4172/2167-7921.1000239. Epub 2017 Apr 28.</citation>
    <PMID>28758052</PMID>
  </reference>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>September 27, 2018</study_first_submitted>
  <study_first_submitted_qc>October 29, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 1, 2018</study_first_posted>
  <last_update_submitted>November 27, 2018</last_update_submitted>
  <last_update_submitted_qc>November 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No Individual Patient Data sharing plan has been implemented</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>April 24, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/18/NCT03726918/Prot_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

